SCHEMBL692809

SCHEMBL692809

CC1=CC=COO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29027353 0.95
SCHEMBL28529992 0.65
SCHEMBL28281416 0.65
SCHEMBL2016425 0.65
Hydrochloric Acid SCHEMBL3401486 0.64
SCHEMBL28586867 0.60
SCHEMBL4710658 0.60
SCHEMBL12474032 0.60
SCHEMBL4743548 0.60
Hydrochloric Acid SCHEMBL3401475 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114191401-A Preparation method of meglumine sublingual tablet 南京斯泰尔医药科技有限公司 2022-03-18 CN claimed
CN-106309392-B Oral fast absorption preparation of methyl digoxin and preparation method thereof 南京斯泰尔医药科技有限公司 2021-10-19 CN claimed
CN-106943346-B Methdigoxin liquid preparation, preparation method and application thereof 山东达因海洋生物制药股份有限公司 2020-02-11 CN claimed
EP-3302439-A1 THERAPEUTIC COMPOSITION Dermac, LLC (US) 2018-04-11 EP claimed
EP-2649989-B1 Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof UNIV KING SAUD (SA) 2017-10-18 EP claimed
US-20170000814-A1 THERAPEUTIC COMPOSITION MARUHO CO., LTD. (JP) 2017-01-05 US claimed
US-20170000813-A1 THERAPEUTIC COMPOSITION MARUHO CO., LTD. (JP) 2017-01-05 US claimed
WO-2016200672-A1 THERAPEUTIC COMPOSITION CUTANEA LIFE SCIENCES, INC. (US) 2016-12-15 WO claimed
US-20160354396-A1 THERAPEUTIC COMPOSITION MARUHO CO., LTD. (JP) 2016-12-08 US claimed
EP-1441705-B1 SOLID, STABILIZED, PROMPT- AND/OR MODIFIED-RELEASE THERAPEUTICAL SYSTEMS FOR THE ORAL ADMINISTRATION OF LIQUID ACTIVE PRINCIPLES, EXCIPIENTS OR FOODSTUFFS FARMATRON LTD (GB) 2014-09-03 EP claimed
JP-4763957-B2 2011-08-31 JP claimed
EP-1280604-B1 MEDIA MILLING JAGOTEC AG (CH) 2008-03-19 EP claimed
US-6604698-B2 Media milling SKYEPHARMA CANADA, INC. (CA) 2003-08-12 US claimed
EP-1280604-A1 MEDIA MILLING RTP Pharma Inc. (US) 2003-02-05 EP claimed
EP-0687172-B1 SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF PHARMACIA AB (SE) 2002-12-04 EP claimed
US-20020003179-A1 Media milling SKYEPHARMA AG (CH) 2002-01-10 US claimed
WO-2001085345-A1 MEDIA MILLING RTP PHARMA INC. (US) 2001-11-15 WO claimed
EP-0037740-B1 SOLID MICRODOSE DRUG PREPARATION YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1985-11-21 EP claimed
US-4198391-A CARDIAC GLYCOSIDE, ETHANOL, WATER, PROPYLENE GLYCOL OR GLYCERINE, POLYOXYETHYLENE GLYCOL R. P. SCHERER LTD. (GB) 1980-04-15 US claimed
US-4067960-A GELATIN CAPSULE, CARDIOTONIC R. P. SCHERER LIMITED (EN) 1978-01-10 US claimed